Climb Bio Inc (CLYM)

Finanzdaten der Climb Bio Inc-Aktie (CLYM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	0.97%15.36	15.21	19.30	14.89	10.68
Research and Development	3.64%9.71	9.37	13.74	9.07	6.58
Operating Income/Loss	0.97%-15.36	-15.21	-19.30	-14.89	-10.68
Nonoperating Income/Loss	24.98%1.86	1.49	-	2.00	2.01
	1.63%-13.50	-13.72	-17.52	-12.89	-8.67
Attributable To Parent	1.63%-13.50	-13.72	-17.52	-12.89	-8.67
Basic Average Shares	11.65%76.15	68.21	0.13	68.00	67.59
Diluted Average Shares	11.65%76.15	68.21	0.13	68.00	67.59
Basic Earnings Per Share	10.00%-0.18	-0.20	-0.25	-0.19	-0.13
Diluted Earnings Per Share	10.00%-0.18	-0.20	-0.25	-0.19	-0.13